Shareholder Information
Investor Overview
NovaBay Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide® compounds, which are novel, synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells. NovaBay's topical Aganocide compounds are being developed to treat and prevent a wide range of infections without causing bacterial resistance. NovaBay has internal development programs aimed at addressing hospital infections, chronic non-healing wounds, UCBE and onychomycosis.
NovaBay has entered into and recently expanded an agreement with Galderma S.A. to develop and commercialize Aganocide compounds in acne, impetigo and other dermatological indications.
Transfer Agent
The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. with the following contact information:
For standard US postal mail
Computershare Trust Company, N.A.
Po Box 43070
Providence, RI 02940-3070
For overnight/express delivery
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
For DWAC instructions provided to brokers
FAST Transfer Agent number – 50173
Telephone and Fax
Toll free in the US +1 800 962 4284
Telephone +1 303-262-0600
Fax +1 303-262-0700
Website
www.computershare.com
eMail inquiries
web.queries@computershare.com
Theresa Granados
(510) 899-8870
